Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05999006 · ClinicalTrials.gov registry record · NA
Safety and Feasibility of the ELIOS System in POAG Patients
A NA study of Glaucoma, Primary Open Angle, sponsored by Elios Vision.
- Recruiting
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 5
- Study locations
NCT05999006: Recruiting NA study of Glaucoma, Primary Open Angle, sponsored by Elios Vision.
NCT05999006 is a NA study of Glaucoma, Primary Open Angle that is actively recruiting participants, run by Elios Vision. The registered enrollment target is 65 participants, above the 58-participant average among 5 other Glaucoma, Primary Open Angle trials with a reported enrollment target (12% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05999006, a NA study of Glaucoma, Primary Open Angle, is actively recruiting participants, sponsored by Elios Vision.
- RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 5
- Study locations
Study Summary
Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)
Primary Outcome
Proportion of subjects who achieve a decrease in mean diurnal IOP (DIOP) from baseline of at least 20% on the same or fewer medications
Conditions Studied
Interventions
- DEVICE ELIOS Procedure
Study Locations (5)
Arizona
- Elios Vision Clinical Site - Glendale
Florida
- Elios Vision Clinical Site - Largo
Illinois
- Elios Vision Clinical Site - Rock Island
Oklahoma
- Elios Vision Clinical Site - Oklahoma City
Wisconsin
- Elios Vision Clinical Site - Kenosha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT05999006 shows while recruiting
NCT05999006 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, above the 58-participant average among 5 other Glaucoma, Primary Open Angle trials with a reported enrollment target (12% higher).
The record links to 1 condition, with Glaucoma, Primary Open Angle appearing as the primary indexed condition, and to 1 intervention - of which ELIOS Procedure is the first listed.
NCT05999006 lists 5 locations in 5 states (Arizona, Florida, Illinois).
Frequently Asked Questions
What is clinical trial NCT05999006 about?
NCT05999006 is a clinical study titled "Safety and Feasibility of the ELIOS System in POAG Patients". Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)
What is the current status of trial NCT05999006?
This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2023-10-18. Estimated completion is 2026-04.
What conditions does trial NCT05999006 study?
This clinical trial studies the following conditions: Glaucoma, Primary Open Angle.
What interventions are being tested in trial NCT05999006?
The interventions under investigation include: ELIOS Procedure (DEVICE).
Who is sponsoring clinical trial NCT05999006?
This trial is sponsored by Elios Vision, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05999006 being conducted?
This trial has 5 study locations across Arizona, Florida, Illinois, Oklahoma, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma, Primary Open Angle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adaptive Optics Retinal Imaging
RECRUITING · NA
-
Caffeine Consumption in Glaucoma Patients and Healthy Subjects
RECRUITING · NA
-
Safety and IOP-Lowering Effects of WB007
COMPLETED · Phase 1
-
Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert
COMPLETED · Phase 4
-
NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI